Companies: 11,396     total market cap: โ‚ฌ132.969 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Adaptimmune Therapeutics
ADAP
#10858
Rank
โ‚ฌ13 M
Marketcap
๐Ÿ‡ฌ๐Ÿ‡ง United Kingdom
Country
0,04907ย โ‚ฌ
Share price
0.00%
Change (1 day)
13.14%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

EPS for Adaptimmune Therapeutics (ADAP)

EPS in 2025 (TTM): -0,04260ย โ‚ฌ

According to Adaptimmune Therapeutics's latest financial reports the company's current EPS (TTM) is -0,05363ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,91ย โ‚ฌ a decrease over its 2021 EPS that were of -0,91ย โ‚ฌ.

EPS history for Adaptimmune Therapeutics from 2016 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,04260ย โ‚ฌ
2022-0,91ย โ‚ฌ-0%
2021-0,91ย โ‚ฌ6.25%
2020-0,86ย โ‚ฌ-27.27%
2019-1,18ย โ‚ฌ29.41%
2018-0,91ย โ‚ฌ20.09%
2017-0,76ย โ‚ฌ-16.73%
2016-0,91ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
uniQure
QURE
-3,70ย โ‚ฌ 6,800.00%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
-1,36ย โ‚ฌ 2,433.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
2,95ย โ‚ฌ-5,600.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-0,19ย โ‚ฌ 250.00%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com